Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036572 | SCV000060227 | benign | not specified | 2010-05-03 | criteria provided, single submitter | clinical testing | This variant is not expected to have clinical significance because it is not loc ated in the conserved region of the splicing consensus sequence and it is a comm on variant in the Black population. |
Invitae | RCV000204723 | SCV000262110 | benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000036572 | SCV000305594 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000317958 | SCV000353348 | likely benign | Hypertrophic cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000372658 | SCV000353349 | likely benign | Left ventricular noncompaction cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000278193 | SCV000353350 | likely benign | Familial restrictive cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000333512 | SCV000353351 | likely benign | Dilated Cardiomyopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001528605 | SCV001159655 | benign | not provided | 2021-07-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001528605 | SCV001939265 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426528 | SCV002743371 | benign | Cardiovascular phenotype | 2014-12-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Cohesion Phenomics | RCV000317958 | SCV003803068 | benign | Hypertrophic cardiomyopathy | 2022-10-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445088 | SCV004173800 | benign | Dilated cardiomyopathy 1D | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445089 | SCV004173801 | benign | Cardiomyopathy, familial restrictive, 3 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445087 | SCV004173802 | benign | Hypertrophic cardiomyopathy 2 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030566 | SCV000053237 | benign | Primary familial hypertrophic cardiomyopathy | 2012-02-22 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV001528605 | SCV001740591 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000036572 | SCV001922675 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001528605 | SCV001928306 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000036572 | SCV001958683 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000036572 | SCV001967254 | benign | not specified | no assertion criteria provided | clinical testing |